Gjb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GJB2 Gene | |
|---|---|
| Full Name | Gap Junction Protein Beta 2 (Connexin 26) |
| Chromosome | 13q11-13 |
| NCBI Gene ID | 2700 |
| OMIM | 121011 |
| Ensembl ID | ENSG00000165474 |
| UniProt ID | P29033 |
| Associated Diseases | Autosomal recessive deafness 1A (DFNB1), Vohwinkel syndrome, Keratitis-ichthyosis-deafness syndrome |
GJB2 encodes connexin 26 (Cx26), a gap junction protein that allows direct cell-to-cell communication through ion and small molecule transfer. In the inner ear, gap junctions are essential for potassium recycling during auditory transduction. Connexin 26 mutations cause the most common form of autosomal recessive deafness. Gap junction dysfunction may contribute to neuronal homeostasis disruptions in neurodegenerative diseases.
The GJB2 gene encodes a protein involved in critical cellular processes in the nervous system. This gene product plays important roles in neuronal development, signal transduction, and cellular homeostasis.
Autosomal recessive deafness 1A (DFNB1), Vohwinkel syndrome, Keratitis-ichthyosis-deafness syndrome are associated with dysfunction in this gene. These conditions highlight the importance of proper GJB2 function in neuronal survival and brain homeostasis.
The diseases associated with GJB2 follow various inheritance patterns including autosomal recessive and autosomal dominant, depending on the specific mutation.
Expression of GJB2 is detected in various brain regions with particular enrichment in areas relevant to neurodegenerative processes. Studies using the Allen Brain Atlas show characteristic expression patterns in the cerebral cortex, hippocampus, and brainstem.
Understanding the role of GJB2 in neurodegeneration may lead to therapeutic interventions targeting the specific molecular pathways affected. Research directions include:
Ongoing research focuses on:
The study of Gjb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
GJB2 encodes Connexin 26 (Cx26), a member of the connexin family of gap junction proteins. There are 21 connexin genes in humans, each named based on molecular weight [1].
Connexin structure:
Two hemichannels (connexons) from adjacent cells dock to form a complete gap junction channel:
The primary function of Cx26 in the inner ear is potassium recycling:
Cx26 is expressed in:
The 35delG mutation is the most common cause of autosomal recessive deafness:
Autosomal dominant mutations cause:
GJB2 mutations cause:
Gap junction dysfunction may contribute to AD pathology:
Connexin expression changes in PD:
Gap junctions propagate excitotoxic signals:
| Approach | Compound | Status |
|---|---|---|
| Gap junction openers | MeFloquine | Research |
| Gap junction blockers | Carbenoxolone | Research |
| Anti-inflammatory | Corticosteroids | Limited |
Effective for GJB2-related deafness:
Goodenough DA, Goliger JA, Paul DL. "Connexins, connexons, and intercellular communication." Annu Rev Biochem. 1996;65:475-502. DOI:10.1146/annurev.bi.65.070196.002455 ↩︎